CareDx (CDNA) Reports Q1 Loss of $0.32

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.32), versus ($0.37) reported last year. Revenue for the quarter came in at $11.58 million, versus $6.56 million reported last year.

eFor the full year 2017, CareDx continues to expect revenue to be in the range of $45 million to $50 million, excluding any potential AlloSure revenue.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• CareDx completes $171.2M sale of lab products unit to Eurobio Scientific
• Nike (NKE) Tops Q4 EPS by 8c
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations